Life After the Pill: Real-World Quality of Life Across CML Drugs and Treatment-Free Remission
A nationwide Israeli survey of 233 CML patients finds overall quality of life is preserved across tyrosine kinase inhibitors, but ...
A nationwide Israeli survey of 233 CML patients finds overall quality of life is preserved across tyrosine kinase inhibitors, but ...
A six-patient Italian real-world case series reports that asciminib achieved sustained molecular responses and a favourable cardiovascular safety profile in ...
The Danish DALIAH phase 3 trial found that low-dose pegylated interferon achieved superior long-term molecular responses to hydroxyurea in myeloproliferative ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine